Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364350 · ClinicalTrials.gov registry record
TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study
A clinical trial of Diabetes Mellitus Type 2 in Obese, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 550
- Enrollment target
- 16
- Study locations
NCT01364350 is a study of Diabetes Mellitus Type 2 in Obese that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 550 participants. The trial reports 16 study locations across 11 states.
The verdict
NCT01364350, a study of Diabetes Mellitus Type 2 in Obese, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 550 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to continue to follow participants in the TODAY clinical trial as they transition to non-blinded, non-randomized standard diabetes care and management with monitoring and follow-up for up to 24 months (phase 1), during which time the TODAY data are analyzed and findings interpreted to develop a long-term observational protocol (phase 2). Data are collected during phase 1 for descriptive purposes; there is no primary hypothesis.
Conditions Studied
Interventions
- OTHER standard of care in general clinical practice
Study Locations (16)
Massachusetts
- Massachusetts General Hospital Diabetes Center - Boston
- Joslin Diabetes Center - Boston
Missouri
- Saint Louis University - St Louis
- Washington University - St Louis
New York
- Columbia University Medical Center - New York
- State University of New York Upstate Medical University - Syracuse
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh - Pittsburgh
Texas
- Baylor College of Medicine - Houston
- University of Texas Health Science Center at San Antonio - San Antonio
California
- Children's Hospital Los Angeles - Los Angeles
Colorado
- University of Colorado Denver - Denver
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01364350
The ClinicalTrials.gov registry entry for NCT01364350 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus Type 2 in Obese appearing as the primary indexed condition, and to 1 intervention - of which standard of care in general clinical practice is the first listed.
NCT01364350 reports 16 study locations spanning 11 distinct geographic areas - top geographies include Massachusetts, Missouri, New York.
Frequently Asked Questions
What is clinical trial NCT01364350 about?
NCT01364350 is a clinical study titled "TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study". The purpose of this study is to continue to follow participants in the TODAY clinical trial as they transition to non-blinded, non-randomized standard diabetes care and management with monitoring and follow-up for up to 24 months (phase 1), during which time the TODAY data are analyzed and findings ...
What is the current status of trial NCT01364350?
This trial is currently completed. The enrollment target is 550 participants. The study started on 2011-03. Estimated completion is 2014-02.
What conditions does trial NCT01364350 study?
This clinical trial studies the following conditions: Diabetes Mellitus Type 2 in Obese.
What interventions are being tested in trial NCT01364350?
The interventions under investigation include: standard of care in general clinical practice (OTHER).
Who is sponsoring clinical trial NCT01364350?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01364350 being conducted?
This trial has 16 study locations across California, Colorado, Connecticut, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus Type 2 in Obese
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.